Skip navigation

Islet cell spheroids produced by a thermally sensitive scaffold: a new diabetes treatment

Islet cell spheroids produced by a thermally sensitive scaffold: a new diabetes treatment

Yao, Xueting, Gong, Zehua, Yin, Wenyan, Hanbing, Li, Douroumis, Dennis ORCID: 0000-0002-3782-0091 , Huang, Lijiang and Li, Huaqiong (2024) Islet cell spheroids produced by a thermally sensitive scaffold: a new diabetes treatment. Journal of Nanobiotechnology, 22:657. ISSN 1477-3155 (Online) (doi:https://doi.org/10.1186/s12951-024-02891-w)

[img]
Preview
PDF (Open Access article)
48546 DOUROUMIS_Islet_Cell_Spheroids_Produced_By_A_Thermally_Sensitive_Scaffold_(OA)_2024.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (4MB) | Preview

Abstract

The primary issues in treating type 1 diabetes mellitus (T1DM) through the transplantation of healthy islets or islet β-cells are graft rejection and a lack of available donors. Currently, the majority of approaches use cell encapsulation technology and transplant replacement cells that can release insulin to address transplant rejection and donor shortages. However, existing encapsulation materials merely serve as carriers for islet cell growth. A new treatment approach for T1DM could be developed by creating a smart responsive material that encourages the formation of islet cell spheroids to replicate their 3D connections in vivo and controls the release of insulin aggregates. In this study, we used microfluidics to create thermally sensitive porous scaffolds made of poly (Nisopropyl acrylamide)/graphene oxide (PNIPAM/GO). The material was carefully shrunk under near-infrared light, enriched with mouse insulinoma pancreatic β cells (β-TC-6 cells), encapsulated, and cultivated to form 3D cell spheroids. The controlled contraction of the thermally responsive porous scaffold regulated insulin release from the spheroids, demonstrated using the glucose-stimulated insulin release assay (GSIS), enzyme-linked immunosorbent assay (ELISA), and immunofluorescence assay. Eventually, implantation of the spheroids into C57BL/6 N diabetic mice enhanced the therapeutic effect, potentially offering a novel approach to the management of T1DM.

Item Type: Article
Uncontrolled Keywords: Type 1 diabetes mellitus, thermally sensitive porous scaffold, thermo-responsiveness, controlled insulin release, β-TC-6 cell spheroids
Subjects: Q Science > Q Science (General)
R Medicine > R Medicine (General)
T Technology > T Technology (General)
Faculty / School / Research Centre / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Science (SCI)
Related URLs:
Last Modified: 06 Nov 2024 09:37
URI: http://gala.gre.ac.uk/id/eprint/48546

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics